ISBN: 9783540529613
This volume is the fourth in a series of annual reports from the European School of Oncology Task Force on Endocrine As- pects - Mechanisms of Breast Cancer. This year's issue con- solida… Mehr…
BetterWorldBooks.com Versandkosten:zzgl. Versandkosten. Details... |
ISBN: 9783540529613
Springer. Used - Very Good. Former Library book. Great condition for a used book! Minimal wear. 100% Money Back Guarantee. Shipped to over one million happy customers. Your purchase ben… Mehr…
Biblio.com |
1990, ISBN: 3540529616
[EAN: 9783540529613], Gebraucht, sehr guter Zustand, [PU: Springer], Former Library book. Great condition for a used book! Minimal wear.
AbeBooks.de Better World Books, Mishawaka, IN, U.S.A. [51315977] [Rating: 5 (von 5)] NOT NEW BOOK Versandkosten: EUR 2.62 Details... |
1990, ISBN: 3540529616
[EAN: 9783540529613], Gebraucht, sehr guter Zustand, [PU: Springer-Verlag Berlin and Heidelberg GmbH & Co. K], Pub_year - 1990.
AbeBooks.de Anstin International Trading, North Vancouver, BC, Canada [58455525] [Rating: 3 (von 5)] NOT NEW BOOK Versandkosten: EUR 6.61 Details... |
ISBN: 9783540529613
Springer. Used - Very Good. Former Library book. Great condition for a used book! Minimal wear., Springer
Biblio.co.uk |
ISBN: 9783540529613
This volume is the fourth in a series of annual reports from the European School of Oncology Task Force on Endocrine As- pects - Mechanisms of Breast Cancer. This year's issue con- solida… Mehr…
ISBN: 9783540529613
Springer. Used - Very Good. Former Library book. Great condition for a used book! Minimal wear. 100% Money Back Guarantee. Shipped to over one million happy customers. Your purchase ben… Mehr…
1990
ISBN: 3540529616
[EAN: 9783540529613], Gebraucht, sehr guter Zustand, [PU: Springer], Former Library book. Great condition for a used book! Minimal wear.
1990, ISBN: 3540529616
[EAN: 9783540529613], Gebraucht, sehr guter Zustand, [PU: Springer-Verlag Berlin and Heidelberg GmbH & Co. K], Pub_year - 1990.
ISBN: 9783540529613
Springer. Used - Very Good. Former Library book. Great condition for a used book! Minimal wear., Springer
Bibliographische Daten des bestpassenden Buches
Autor: | |
Titel: | |
ISBN-Nummer: |
Detailangaben zum Buch - Endocrine Therapy of Breast Cancer IV: v. 4 (ESO Monographs)
EAN (ISBN-13): 9783540529613
ISBN (ISBN-10): 3540529616
Gebundene Ausgabe
Erscheinungsjahr: 1990
Herausgeber: Springer
Buch in der Datenbank seit 2009-02-15T11:52:39+01:00 (Berlin)
Detailseite zuletzt geändert am 2019-10-10T05:31:51+02:00 (Berlin)
ISBN/EAN: 9783540529613
ISBN - alternative Schreibweisen:
3-540-52961-6, 978-3-540-52961-3
Alternative Schreibweisen und verwandte Suchbegriffe:
Titel des Buches: endocrine therapies breast cancer, endocrine therapy breast cancer, eso
Daten vom Verlag:
Autor/in: Aron Goldhirsch
Titel: ESO Monographs; Endocrine Therapy of Breast Cancer IV
Verlag: Springer; Springer Berlin
97 Seiten
Erscheinungsjahr: 1990-09-28
Berlin; Heidelberg; DE
Gedruckt / Hergestellt in Deutschland.
Gewicht: 0,540 kg
Sprache: Englisch
139,09 € (DE)
142,99 € (AT)
143,00 CHF (CH)
Not available, publisher indicates OP
BB; Book; Hardcover, Softcover / Medizin/Klinische Fächer; Onkologie; Verstehen; breast cancer; hormone; molecular genetics; systemic therapy; Ovarsuppression; genetics; steroid; cancer; hormones; carcinogenesis; Hormonrezeptoren; cell; oncology; chemotherapy; hormone receptors; C; Oncology; Medicine; Endocrinology; Gynecology; Endokrinologie; Gynäkologie und Geburtshilfe; BC; EA
Role of Oestrogen and Progestin in Human Mammary Carcinogenesis.- Molecular Genetics of Steroid Hormone Receptors.- Prognostic Factors in Breast Cancer.- Prognostic Factors in Node-Negative Breast Cancer Patients.- Long-Term Tamoxifen Therapy: An Appropriate Chemosuppressive Treatment for Breast Cancer.- Tamoxifen as an Agonist for Metastatic Breast Cancer.- A Review of the International Experience with the LHRH Agonist Zoladex in the Treatment of Advanced Breast Cancer in Pre- and Perimenopausal Women.- Adjuvant Systemic Therapy in Node-Negative Breast Cancer.- Adjuvant Chemotherapy in Premenopausal Breast Cancer Patients is Effective by Means Other than Ovarian Function Suppression.- Alternative Methods for Describing Treatment Benefit Including Quality-of-Life Considerations.Weitere, andere Bücher, die diesem Buch sehr ähnlich sein könnten:
Neuestes ähnliches Buch:
9780387529615 Endocrine Therapy of Breast Cancer, IV (European School of Oncology Monographs) (A. Goldhirsch)
- 9780387529615 Endocrine Therapy of Breast Cancer, IV (European School of Oncology Monographs) (A. Goldhirsch)
- 9780387576909 Endocrine Therapy of Breast Cancer VI (European School of Oncology Monographs) (Howell, A.)
- 9780387557182 Endocrine Therapy of Breast Cancer V (Eso Monographs (European School of Oncology)) (Editor-A. Goldhirsch)
- 9783540295778 Rationality and Equilibrium (Charalambos D. Aliprantis; Rosa L. Matzkin; Daniel L. McFadden; James C. Moore; Nicholas C. Yannelis)
< zum Archiv...